Podbit · Dwarkesh Podcast
In Newtonian physics it's just a coincidence that inertial mass and gravitational mass are identical. But we've tested it to 1 part in 10^15. Einstein refused to accept a coincidence that precise. That refusal became the core of general relativity.
Where this was said
At 12:55 · chapter starts 0:00
Brown opens his mini-lecture with Newton's second law (F = ma), his first law (zero force means straight-line motion), and then his gravitational force law: F = GMm/r². He flags the immediate problem — Newton's law implies that jiggling the Sun would instantaneously change the gravitational force felt at Earth, violating the finiteness of the speed of light. He draws a historical parallel to the electrostatic force law, which faced the same problem and was resolved by Maxwell's full theory of electromagnetism. That success story sets up the hope — and the difficulty — of doing something analogous for gravity.
Einstein took roughly 10 years of dogged pursuit from his 'happiest thought' in 1907 to writing down the final form of general relativity in 1915.
Electrostatics was upgraded into a relativistically consistent Maxwell theory, and you'd think you could do the same for gravity. But there's a sign flip: like charges repel, like masses attract. Do the same math and you get a theory where gravity repels. That forced Einstein down a completely different path.
The equality of inertial mass and gravitational mass — Einstein's central clue for general relativity — has been confirmed experimentally to 1 part in 10^15.
Social norms compress behavior so effectively that we assume other minds are similar to ours. They almost never are. After running over 100 psychology studies, Greenberg's biggest finding is that humans are far more different from each other than we intuitively believe.
The widely shared claim that we have a credit card's worth of plastic in our brains may be a massive overestimate. Researchers used nitrile gloves to measure microplastics — and nitrile gloves shed microplastic particles onto the measuring device. A second paper found the original tool used was unreliable, and that we may have far less plastic than reported.
RSD isn't just hurt feelings — it's a dopamine-deficient brain with a hyperactive amygdala and a frayed connection to the prefrontal cortex. Add a surge of norepinephrine and you get chest pain, sweating, and trembling that convinces your body something catastrophic is happening.
In Dan Ariely's door experiment, participants sacrificed the highest-reward door — repeatedly — just to avoid seeing other doors disappear. Even when researchers trained them to use the best door, they kept wasting clicks to maintain options. This is the bias that runs our lives: we'll take a worse outcome to preserve the feeling of optionality.
Dan Gilbert discovered that the brain has a 'psychological immune system' — it misremembers, reframes, and rationalizes to keep you satisfied with whatever you chose. The fear before commitment is all about potential regret. But after committing, your brain quietly starts justifying the choice — and the more irreversible the decision, the stronger the effect.
The psychological immune system can get you through the first few months of any commitment. But durable, long-term well-being requires self-concordance — choosing commitments that are genuinely aligned with your values and what you actually want. Without that alignment, the satisfaction fades fast.
Vision didn't just help animals find food — it ignited the Cambrian explosion of speciation. Half of the human cortex is devoted to visual processing, and that same visual hierarchy directly inspired the neural network architectures powering today's AI.
Peptides come loaded with a powerful narrative: regenerative, subcutaneous, targeted, cutting-edge. That narrative can genuinely move outcomes, especially for pain, energy, and recovery. The RCT's job is to quantify how much additional benefit comes from the molecule itself — above and beyond the compelling story surrounding it.
A pharmaceutical is not an amino acid sequence — it is the successful solution to manufacturing, purification, formulation, and consistency challenges. When clinical trials prove a drug works, they validate a specific product under specific processes, not every preparation that shares the same sequence.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.